| PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... Science translational medicine 10 (460), eaar8356, 2018 | 253 | 2018 |
| Filifactor alocis–a new emerging periodontal pathogen AW Aruni, A Mishra, Y Dou, O Chioma, BN Hamilton, HM Fletcher Microbes and infection 17 (7), 517-530, 2015 | 114 | 2015 |
| Filifactor alocis: The Newly Discovered Kid on the Block with Special Talents W Aruni, O Chioma, HM Fletcher Journal of Dental Research 93 (8), 725-732, 2014 | 88 | 2014 |
| Focus: Infectious Diseases: Role of Microbial Agents in Pulmonary Fibrosis OS Chioma, WP Drake The Yale journal of biology and medicine 90 (2), 219, 2017 | 71 | 2017 |
| Role of the microbiome in interstitial lung diseases OS Chioma, LE Hesse, A Chapman, WP Drake Frontiers in Medicine 8, 595522, 2021 | 34 | 2021 |
| Aflatoxin-mediated sperm and blood cell abnormalities in mice fed with contaminated corn SO Fapohunda, CN Ezekiel, OA Alabi, A Omole, SO Chioma Mycobiology 36 (4), 255-259, 2008 | 28 | 2008 |
| Filifactor alocis collagenase can modulate apoptosis of normal oral keratinocytes O Chioma, AW Aruni, TA Milford, HM Fletcher Molecular oral microbiology 32 (2), 166-177, 2017 | 19 | 2017 |
| Gut microbiota modulates lung fibrosis severity following acute lung injury in mice OS Chioma, EK Mallott, A Chapman, JC Van Amburg, H Wu, ... Communications Biology 5 (1), 1401, 2022 | 10 | 2022 |
| PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF- 1 production LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... Sci. Transl. Med 10, 0 | 6 | |
| PD-1 up-regulation on CD4 (+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production. Sci Transl Med 10 LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... | 5 | 2018 |
| Low Gut Microbial Diversity Augments Estrogen-Driven Pulmonary Fibrosis in Female-Predominant Interstitial Lung Disease OS Chioma, E Mallott, B Shah-Gandhi, ZD Wiggins, M Langford, ... Cells 12 (5), 766, 2023 | 1 | 2023 |
| The Role of Collagen Interacting Proteins in the Pathogenesis of Filifactor alocis OS Chioma Loma Linda University, 2016 | 1 | 2016 |
| Gut Microbiota Induces Pulmonary CD4+ IL-6+ Expression Through PD-1/HIF-1α Signaling in Mice A Souquette, OS Chioma, H Wu, A Gelbard, S Rea, J Prescrille, WP Drake A102. EVALUATING THE INTERSECTION BETWEEN AUTOIMMUNITY, IMMUNODEFICIENCY …, 2024 | | 2024 |
| Gut Microbiota Induce Pulmonary IL-6 Expression Through HIF-1α Signaling in Murine ILD Models S Rea, OS Chioma, HM Wu, WP Drake A32. BENCH TO BEDSIDE IN ILD, A1333-A1333, 2024 | | 2024 |
| Analysis of Murine Stool Reveals Significant Alteration of the Fecal Metabolome in Tryptophan Metabolism T Venkataraman, T Gourdin, J Pescrille, OS Chioma, WP Drake A31. IMMUNE CELL MOLECULAR ACTIVATION SWITCH IN LUNG INJURY AND INFLAMMATION …, 2024 | | 2024 |
| Lactobacillus Rhamnosus Supernatant Insufficient in Limiting the Adverse Effects of Bleomycin Induced Lung Fibrosis A Lancaster, OS Chioma, Z Wiggins, M Langford, WP Drake A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD, A2258-A2258, 2023 | | 2023 |
| The Effect of Quercetin on Human Lung Fibroblasts and Regulation of Collagen Production Z Wiggins, OS Chioma, WP Drake, M Langford A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD, A2259-A2259, 2023 | | 2023 |
| Programmed Cell Death Protein 1 (PD-1) Is an Effective Inducer of IL-6 Expression in Sarcoidosis CD4+ T Cells OS Chioma, H Wu, Z Wiggins, M Langford, WP Drake A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD, A2245-A2245, 2023 | | 2023 |
| Low Gut Microbial Diversity Is Associated with Increased Gut Permeability in Murine Models of Interstitial Lung Disease N Dey, JC Van Amburg, OS Chioma, LE Hesse, EK Mallot, ... B101. VARIED OMICS TECHNIQUES APPLIED TO ALLERGIC AND RESPIRATORY TRAITS …, 2022 | | 2022 |
| Systemic soluble Programmed Death-Ligand 1 levels in sarcoidosis subjects does not vary with disease progression B Shah-Gandhi, OS Chioma, KA Abel, EM Wilfong, WR Mason, WP Drake Medical Research Archives 9 (9), 2021 | | 2021 |
